Biography:Alex Toker
From HandWiki
Prof. Alex Toker | |
|---|---|
| Alma mater |
|
| Scientific career | |
| Fields | Biology, cell biology, apoptosis, Cancer |
| Institutions |
|
Alex Toker is currently a professor at the Department of Pathology at Beth Israel Deaconess Medical Center, Harvard Medical School and Chief of the Division of Signal Transduction and Associate Director of the Cancer Research Institute in the Cancer Center.[1][2] Toker is an expert in the signaling mechanisms that govern cancer progression.[3] His research focus on understanding mechanism of cancer including tumor cell survival, invasion and metastasis. He is currently editor-in-chief of the Journal of Biological Chemistry.[4][5]
In 2022 Toker was the recipient of the Avanti Award in Lipids.[6]
References
- ↑ "Home". http://www.tokerlab.com/.
- ↑ "Alex Toker | Harvard Catalyst Profiles | Harvard Catalyst". https://connects.catalyst.harvard.edu/Profiles/display/Person/84340.
- ↑ "ASBMB names 2022 award winners" (in en). https://www.asbmb.org/asbmb-today/people/082621/asbmb-names-2022-award-winners.
- ↑ "Journal of Biological Chemistry names new editor-in-chief" (in en). https://www.asbmb.org/asbmb-today/people/073021/jbc-names-new-editor-2021.
- ↑ "Journal of Biological Chemistry". https://www.jbc.org/editor-in-chief.
- ↑ "Avanti Awards in Lipids" (in en-US). https://avantilipids.com/about-us/awards.
 |  |
